Objective:To understand the status and tendency of coal-burning-borne endemic fluorosis after implementation of prevention and control measures in Jiangxi Province.Methods:According to the requirements of the national "Coal-burning-borne Endemic Fluorosis Monitoring Program", 3 fixed monitoring villages and 5 non-fixed monitoring villages in Luxi, Shangli were selected as monitoring sites every year from 2014 to 2018, respectively, 10 households were selected by simple random method in each village to survey the usage of stove and health behavior related to the consumption of pepper. At the same time, dental fluorosis and urinary fluoride were monitored in children aged 8 - 12 years in fixed monitoring villages.Results:There were significant differences in the utilization rate of improved stoves, the utilization rate of electric cookers and the qualified rate of improved stoves in fixed monitoring villages between each year (χ 2 = 111.70, 83.96, 36.64, P < 0.05), but there was no significant difference in the correct utilization rate of qualified improved stoves(χ 2 = 2.35, P > 0.05). There were significant differences in the utilization rate of improved stoves, the utilization rate of electric cookers, the qualified rate of improved stoves and the correct utilization rate of qualified improved stoves in non-fixed monitoring villages between each year (χ 2 = 132.32, 42.63, 50.03, 15.29, P < 0.05). There was no significant difference in pepper correct drying rates between fixed monitoring villages and non-fixed monitoring villages between each year (χ 2 = 4.068, 3.436, P > 0.05), the rate of pepper correct keeping and washing methods was 100% in monitored villages each year. From 2014 to 2018, the detection rate of dental fluorosis in children aged 8 - 12 years decreased from 17.04% (106/622) to 6.68% (90/1 347), and showed a downward trend year by year (χ 2trend = 72.60, P < 0.01). The annual geometric mean of urinary fluoride of children was 0.77, 0.74, 0.71, 0.74 and 0.72 mg/L, respectively. There was no significant difference among years ( H = 4.142, P > 0.05). Conclusion:Remarkable achievements have been made in the prevention and control of coal-burning-borne endemic fluorosis in Jiangxi Province.

OBJECTIVETo investigate the effect of transforming growth factor-β1 (TGF-β1) on the differentiation of bone marrow-derived mesenchymal stem cells (MSCs) into cancer-associated fibroblasts(CAFs).

METHODSMSCs were cultured in α-MEM with recombinant human TGF-β1 or in tumor-conditioned medium.The expression of CAFs markers were detected by immunofluorescence and quantitative RT-PCR.

RESULTSThe qRT-PCR assay showed that the expression of CAFs markers FAP, ACTA, CAV, CCL5, CXCR4, FSP1, SDF-1 and vimentin were 9.92±2.16, 7.76±1.28, 3.04±0.95, 3.28±2.16, 2.13±0.71, 1.41±0.66, 2.25±0.86 and 1.38±0.56, respectively, significantly upregulated in the MSCs co-cultured with TGF-β1 or TCM. The relative levels of FAP, ACTA, CAV, CCL5, CXCR4, FSP1, SDF-1 and vimentin mRNA in the TCM group were 7.52±1.76, 5.02±1.18, 1.98±1.19, 1.82±1.19, 2.95±0.86, 1.44±0.67, 2.08±0.74 and 1.47±0.55, respectively, indicating that MSCs can express CAFs phenotype.TGF beta signaling pathway inhibitor SB-431542 could inhibit the differentiation. Both immunofluorescence and Western blot confirmed the above results.

CONCLUSIONSTGF-β1 induces differentiation of local MSCs to CAFs by upregulating the expression of pSmad3, so as to further promote the growth of cancer cells.

Benzamides ; pharmacology ; Bone Marrow Cells ; cytology ; Cell Differentiation ; drug effects ; Cell Line, Tumor ; Chemokine CXCL12 ; metabolism ; Coculture Techniques ; Culture Media, Conditioned ; Dioxoles ; pharmacology ; Fibroblasts ; cytology ; Humans ; Mesenchymal Stromal Cells ; cytology ; drug effects ; Organic Chemicals ; Receptors, CXCR4 ; metabolism ; Recombinant Proteins ; pharmacology ; Smad3 Protein ; metabolism ; Transforming Growth Factor beta1 ; antagonists & inhibitors ; pharmacology ; Vimentin ; metabolism

OBJECTIVE: To compare the treatment outcome and prognosis of the newly-treated myc METHODS: 152 double-expression lymphoma patients (myc RESULTS: The median age of 152 DEL patients was 60.5 years old (15-87 years old). 85 patients (55.9%) were Ann Arbor stage III/IV. There was no significant difference in clinical data between the patients in the two groups. Multivariate Cox regression analysis showed that bcl-6 expression, ECOG score, and stage were the independent prognostic factors for the entire group of DEL patients. There was no statistical difference in ORR between the patients in the two groups (χ2=0.749, P=0.387). Kaplan-Meier survival analysis showed that PFS and OS of the bcl-6 CONCLUSION bcl-6
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols ; Cyclophosphamide ; Doxorubicin ; Humans ; Lymphoma, Large B-Cell, Diffuse/drug therapy* ; Middle Aged ; Prednisolone ; Prognosis ; Vincristine/therapeutic use* ; Young Adult

Objective: To determine whether the adenine base editor (ABE7.10) can be used to fix harmful mutations in the human G6PC3 gene. Methods: To investigate the safety of base-edited embryos, off-target analysis by deep sequencing was used to examine the feasibility and editing efficiency of various sgRNA expression vectors. The human HEK293T mutation models and human embryos were also used to test the feasibility and editing efficiency of correction. Results: ①The G6PC3(C295T) mutant cell model was successfully created. ②In the G6PC3(C295T) mutant cell model, three distinct Re-sgRNAs were created and corrected, with base correction efficiency ranging from 8.79% to 19.56% . ③ ABE7.10 could successfully fix mutant bases in the human pathogenic embryo test; however, base editing events had also happened in other locations. ④ With the exception of one noncoding site, which had a high safety rate, deep sequencing analysis revealed that the detection of 32 probable off-target sites was <0.5% . Conclusion: This study proposes a new base correction strategy based on human pathogenic embryos; however, it also produces a certain nontarget site editing, which needs to be further analyzed on the PAM site or editor window.
Humans ; Gene Editing ; CRISPR-Cas Systems ; Adenine ; HEK293 Cells ; Mutation ; Glucose-6-Phosphatase/metabolism*